TS Financial Group (TSFG)’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-25
Closed -$8K 830
2025
Q3
$8K Buy
+25
New +$7.78K ﹤0.01% 601
2024
Q4
Sell
-40
Closed -$21K 762
2024
Q3
$21K Buy
+40
New +$21.4K ﹤0.01% 394
2023
Q4
Sell
-5
Closed -$2K 930
2023
Q3
$2K Hold
5
﹤0.01% 817
2023
Q2
$2K Buy
5
+1
+25% +$461 ﹤0.01% 824
2023
Q1
$2K Hold
4
﹤0.01% 808
2022
Q4
$2K Hold
4
﹤0.01% 809
2022
Q3
$2K Hold
4
﹤0.01% 780
2022
Q2
$2K Hold
4
﹤0.01% 786
2022
Q1
$2K Hold
4
﹤0.01% 781
2021
Q4
$2K Buy
+4
New +$1.68K ﹤0.01% 754

Other funds holding ELV

TS Financial Group (TSFG)'s ELV Position: Q4 2025 in Review

TS Financial Group (TSFG) sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 25 shares — an estimated $8K sold.

TS Financial Group (TSFG) first reported a position in ELV in Q4 2021 and held it in 10 quarters. The position peaked at $21K in Q3 2024. 1,554 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • TS Financial Group (TSFG) reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • TS Financial Group (TSFG) sold 25 Elevance Health shares in Q4 2025, an estimated $8K.
  • TS Financial Group (TSFG) first reported a position in Elevance Health in Q4 2021 and held it in 10 quarters.
  • TS Financial Group (TSFG)'s Elevance Health position peaked at $21K in Q3 2024.
  • 1,554 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on TS Financial Group (TSFG)'s 13F filing for Q4 2025, filed 4 Feb 2026.